









































The attitude towards psychotropic medications of depressed patients, 
































































































































































⾲ 1 ᑐ㇟⪅ࡢ⫼ᬒ 
 
 



























ᖺ㱋 45.0±11.8 25-69 
ྠᒃ⪅䛾᭷↓ ༢㌟ 2 (8.3)
ྠᒃ 22 (91.7)









἞⒪ᮇ㛫䚷䚷䚷䚷䚷䚷n=17 53.4±39.3 3-148 
ධ㝔ᅇᩘ䚷           n=10 1.9䚷±䚷1.1 1-4
᭹⸆㑂Ᏺ⋡ 95.8 ±11.3 50-100
CSQ-8J 24.1 ±  5.8 8-32
DAI-10 6.7  ± 2.6 0-10
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⾲ 3 ┳ㆤࢣ࢔ࡢᕼᮃࡢ᭷↓࡟ࡼࡿ DAI-10 ࡢẚ㍑ 
 
㸦㧗ࡉ 24.68mmᖜ 156.37mm㸧 
ᕼᮃ࠶ࡾ ᕼᮃ࡞ࡋ ᕼᮃ࠶ࡾ ᕼᮃ࡞ࡋ ᕼᮃ࠶ࡾ ᕼᮃ࡞ࡋ
n=17 n=5 n=13 n=9 n=13 n=9
ᖹᆒ䠄SD) ᖹᆒ䠄SD) ᖹᆒ䠄SD) ᖹᆒ䠄SD) ᖹᆒ䠄SD) ᖹᆒ䠄SD)
DAI-10 6.2(3.0) 5.0(0.7) -1.98  0.05 7.6(2.6) 5.3(1.9) -2.53  0.01 7.4(2.9) 5.7(1.7) -2.02  0.04
Mann-Whitney䛾U᳨ᐃ䚷* : p < 0.05
SD:ᶆ‽೫ᕪ
䛖䛴⑓䛾⑕≧䛻㛵䛩䜛䜿䜰 ᭹⸆䛻㛵䛩䜛䜿䜰 ᑐே㛵ಀ䛻㛵䛩䜛䜿䜰
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